HOME › DRUGS › LINVOSELTAMAB-GCPT
ACTIVE SUBSTANCE / INN

LINVOSELTAMAB-GCPT

Brand name(s): LYNOZYFIC
FDA LISTED
PRESCRIPTION
BLA761400
ACTIVE SUBSTANCE
Linvoseltamab-Gcpt
REGULATORS
FDA
SPONSORS / MAH
RENGENERON PHARMACEUTICALS, INC.
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LYNOZYFICBLA761400RENGENERON PHARMACEUTICALS, INC.Prescription

FULL INTELLIGENCE ON LINVOSELTAMAB-GCPT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →